Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Seyberth, HW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 78 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weber, S; Schneider, L; Peters, M; Misselwitz, J; Ronnefarth, G; Boswald, M; Bonzel, KE; Seeman, T; Sulakova, T; Kuwertz-Broking, E; Gregoric, A; Palcoux, JB; Tasic, V; Manz, F; Scharer, K; Seyberth, HW; Konrad, M
      Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    2. Weber, S; Schlingmann, KP; Peters, M; Nejsum, LN; Nielsen, S; Engel, H; Grzeschik, KH; Seyberth, HW; Grone, HJ; Nusing, R; Konrad, M
      Primary gene structure and expression studies of rodent paracellin-1

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    3. Peters, M; Jeck, N; Seyberth, HW; Konrad, M
      Hereditary hypokalemic salt-losing tubulopathies: Bartter-like syndromes

      RARE KIDNEY DISEASES
    4. Stier, C; Schweer, H; Jelinek, J; Watzer, B; Seyberth, HW; Leonhardt, A
      Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F-2-isoprostanes and 8-epi-prostaglandin F-2 alpha

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    5. Jeck, N; Derst, C; Wischmeyer, E; Ott, H; Weber, S; Rudin, C; Seyberth, HW; Daut, J; Karschin, A; Konrad, M
      Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome

      KIDNEY INTERNATIONAL
    6. Kammerl, MC; Nusing, RM; Seyberth, HW; Riegger, GAJ; Kurtz, A; Kramer, BK
      Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    7. Jeck, N; Reinalter, SC; Henne, T; Marg, W; Mallmann, R; Pasel, K; Vollmer, M; Klaus, G; Leonhardt, A; Seyberth, HW; Konrad, M
      Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness

      PEDIATRICS
    8. Reinhardt, D; Seyberth, HW
      Editorial

      MONATSSCHRIFT KINDERHEILKUNDE
    9. Reinhardt, D; Seyberth, HW
      New section: Pharmacotherapy in childhood

      MONATSSCHRIFT KINDERHEILKUNDE
    10. Horneff, G; Forster, J; Seyberth, HW; Michels, H
      Recommendations of the working group for pediatric rheumatology on therapywith etanercept. Commission for pharmacotherapy

      MONATSSCHRIFT KINDERHEILKUNDE
    11. Reinalter, SC; Grone, HJ; Konrad, M; Seyberth, HW; Klaus, G
      Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies

      JOURNAL OF PEDIATRICS
    12. Nusing, RM; Reinalter, SC; Peters, M; Komhoff, M; Seyberth, HW
      Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    13. Konrad, M; Vollmer, M; Lemmink, HH; Van den Heuvel, LPWJ; Jeck, N; Vargas-Poussou, R; Lakings, A; Ruf, R; Deschenes, G; Antignac, C; Guay-Woodford, L; Knoers, NVAM; Seyberth, HW; Feldmann, D; Hildebrandt, F
      Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    14. Weber, S; Hoffmann, K; Jeck, N; Saar, K; Boeswald, M; Kuwertz-Broeking, E; Meij, IIC; Knoers, NVAM; Cochat, P; Sulakova, T; Bonzel, KE; Soergel, M; Manz, F; Schaerer, K; Seyberth, HW; Reis, A; Konrad, M
      Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene

      EUROPEAN JOURNAL OF HUMAN GENETICS
    15. Watzer, B; Reinalter, S; Seyberth, HW; Schweer, H
      Determination of free and glucuronide conjugated 20-hydroxy-arachidonic acid (20-HETE) in urine by gas chromatography/negative ion chemical ionization mass spectrometry

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    16. Vollmer, M; Jeck, N; Lemmink, HH; Vargas, R; Feldmann, D; Konrad, M; Beekmann, F; van den Heuvel, LPWJ; Deschenes, G; Guay-Woodford, LM; Antignac, C; Seyberth, HW; Hildebrandt, F; Knoers, NVAM
      Antenatal Bartter syndrome with sensorineural deafness: refinement of the locus on chromosome 1p31

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    17. Jeck, N; Konrad, M; Hess, M; Seyberth, HW
      The diuretic- and Bartter-like salt-losing tubulopathies

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    18. Horneff, G; Forster, J; Seyberth, HW; Michels, H
      Treatment of Etanercept (P75 TNF-alpha-receptor immunoglobulin fusion protein) - Recommendations of the Kommission Pharmakotherapie

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    19. Komhoff, M; Jeck, NDM; Seyberth, HW; Grone, HJ; Nusing, RM; Breyer, MD
      Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome

      KIDNEY INTERNATIONAL
    20. Jeck, N; Konrad, M; Peters, M; Weber, S; Bonzel, KE; Seyberth, HW
      Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype

      PEDIATRIC RESEARCH
    21. Knoppel, C; Klinger, O; Soergel, M; Seyberth, HW; Leonhardt, A
      Use of medicine without authorization or without authorization in children

      MONATSSCHRIFT KINDERHEILKUNDE
    22. Wegmann, M; Kampen, A; Weber, S; Seyberth, HW; Kockerling, A
      Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    23. Jeck, N; Konrad, M; Seyberth, HW
      Hereditary hypokalemic salt-losing tubulopathies

      CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS
    24. Girschick, HJ; Seyberth, HW; Huppertz, HI
      Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatorydrugs

      BONE
    25. Cawello, W; Kuhlmann, U; Schweer, H; Samadi, N; Gerloff, J; Wilberz, S; Seyberth, HW; Lange, H
      Pharmacokinetics of alprostadil (prostaglandin E-1) in patients undergoinghaemodialysis

      CLINICAL DRUG INVESTIGATION
    26. Morath, R; Klein, T; Seyberth, HW; Nusing, RM
      Immunolocalization of the four prostaglandin E-2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    27. Cawello, W; Samadi, N; Schweer, H; Wilberz, S; Kuhlmann, U; Lange, H; Seyberth, HW
      Pharmacokinetics of prostaglandin E-1 in patients undergoing haemodialysis

      VASA-JOURNAL OF VASCULAR DISEASES
    28. Konrad, M; Leonhardt, A; Hensen, P; Seyberth, HW; Kockerling, A
      Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes

      PEDIATRICS
    29. KAROLYI L; KOCH MC; GRZESCHIK KH; SEYBERTH HW
      THE MOLECULAR-GENETIC APPROACH TO BARTTERS-SYNDROME

      Journal of molecular medicine
    30. KOMHOFF M; LESENER B; NAKAO K; SEYBERTH HW; NUSING RM
      LOCALIZATION OF THE PROSTACYCLIN RECEPTOR IN HUMAN KIDNEY

      Kidney international
    31. LEMMINK HH; KNOERS NVAM; KAROLYI L; VANDIJK H; NIAUDET P; ANTIGNAC C; GUAYWOODFORD LM; GOODYER PR; CAREL JC; HERMES A; SEYBERTH HW; MONNENS LAH; VANDENHEUVEL LPWJ
      NOVEL MUTATIONS IN THE THIAZIDE-SENSITIVE NACL COTRANSPORTER GENE IN PATIENTS WITH GITELMAN-SYNDROME WITH PREDOMINANT LOCALIZATION TO THE C-TERMINAL DOMAIN

      Kidney international
    32. LESENER B; KOMHOFF M; SEYBERTH HW; NUSING RM
      EXPRESSION OF PROSTACYCLIN RECEPTOR PROTEIN AND MESSENGER-RNA IN HUMAN KIDNEY

      Naunyn-Schmiedeberg's archives of pharmacology
    33. MORATH R; KLEIN T; SEYBERTH HW; NUSING RM
      EXPRESSION OF THE PROSTAGLANDIN E-2 RECEPTORS EP1, EP2, EP3 AND EP4 IN HUMAN KIDNEY

      Naunyn-Schmiedeberg's archives of pharmacology
    34. NUSING RM; REINALTER S; KLEIN T; SEYBERTH HW
      USE OF A CYCLOOXYGENASE-2 SPECIFIC INHIBITOR FOR TREATMENT OF HYPERPROSTAGLANDINE SYNDROME

      Naunyn-Schmiedeberg's archives of pharmacology
    35. JECK N; KONRAD M; WEBER S; REINALTER S; SEYBERTH HW
      MUTATIONS IN CLCKB-CHANNEL CAUSE BARTTER-SYNDROME

      Naunyn-Schmiedeberg's archives of pharmacology
    36. DERST C; WISCHMEYER E; PREISIGMULLER R; SPAUSCHUS A; KONRAD M; HENSEN P; JECK N; SEYBERTH HW; DAUT J; KARSCHIN A
      A HYPERPROSTAGLANDIN-E SYNDROME MUTATION IN KIR1.1 (RENAL OUTER MEDULLARY POTASSIUM) CHANNELS REVEALS A CRUCIAL RESIDUE FOR CHANNEL FUNCTION IN KIR1.3 CHANNELS

      The Journal of biological chemistry
    37. VARGASPOUSSOU R; FELDMANN D; VOLLMER M; KONRAD M; KELLY L; VANDENHEUVEL LPWJ; TEBOURBI L; BRANDIS M; KAROLYI L; HEBERT SC; LEMMINK HH; DESCHENES G; HILDEBRANDT F; SEYBERTH HW; GUAYWOODFORD LM; KNOERS NVAM; ANTIGNAC C
      NOVEL MOLECULAR VARIANTS OF THE NA-K-2CL COTRANSPORTER GENE ARE RESPONSIBLE FOR ANTENATAL BARTTER-SYNDROME

      American journal of human genetics
    38. SCHWEER H; WATZER B; SEYBERTH HW; NUSING RM
      IMPROVED QUANTIFICATION OF 8-EPI-PROSTAGLANDIN F2-ALPHA AND F-2-ISOPROSTANES BY GAS-CHROMATOGRAPHY TRIPLE-STAGE QUADRUPOLE MASS-SPECTROMETRY - PARTIAL CYCLOOXYGENASE-DEPENDENT FORMATION OF 8-EPI-PROSTAGLANDIN F2-ALPHA IN HUMANS

      Journal of mass spectrometry.
    39. KURTZ CL; KAROLYI L; SEYBERTH HW; KOCH MC; VARGAS R; FELDMANN D; VOLLMER M; KNOERS NVAM; MADRIGAL G; GUAYWOODFORD LM
      A COMMON NKCC2 MUTATION IN COSTA-RICAN BARTTERS-SYNDROME PATIENTS - EVIDENCE FOR A FOUNDER EFFECT

      Journal of the American Society of Nephrology
    40. KONRAD M; KOCKERLING A; LEONHARDT A; KAROLYI L; SEYBERTH HW
      PRE-NATAL AND POSTNATAL MANAGEMENT OF HYPERPROSTAGLANDIN-E SYNDROME (HPS) FOLLOWING MOLECULAR-GENETIC DIAGNOSIS FROM AMNIOCYTES

      Journal of the American Society of Nephrology
    41. KONRAD M; HENSEN P; KAROLYI L; SEYBERTH HW
      NOVEL ROMK (KCNJ1) MUTATIONS IN 2 SPORADIC CASES WITH HYPERPROSTAGLANDIN-E SYNDROME (ANTENATAL BARTTER-SYNDROME)

      Journal of the American Society of Nephrology
    42. KAROLYI L; KONRAD M; KOCKERLING A; ZIEGLER A; ZIMMERMANN DK; ROTH B; WIEG C; GRZESCHIK KH; KOCH MC; SEYBERTH HW; VARGAS R; FORESTIER L; JEAN G; DESCHAUX M; RIZZONI GF; NIAUDET P; ANTIGNAC C; FELDMANN D; LORRIDON F; COUGOUREUX E; LAROZE F; ALESSANDRI JL; DAVID L; SAUNIER P; DESCHENES G; HILDEBRANDT F; VOLLMER M; PROESMANS W; BRANDIS M; VANDENHEUVEL LPWJ; LEMMINK HH; NILLESEN W; MONNENS LAH; KNOERS NVAM; GUAYWOODFORD LM; WRIGHT CJ; MADRIGAL G; HEBERT SC
      MUTATIONS IN THE GENE ENCODING THE INWARDLY-RECTIFYING RENAL POTASSIUM CHANNEL, ROMK, CAUSE THE ANTENATAL VARIANT OF BARTTER-SYNDROME - EVIDENCE FOR GENETIC-HETEROGENEITY (VOL 6, PG 17, 1997)

      Human molecular genetics
    43. KAROLYI L; KONRAD M; KOCKERLING A; ZIEGLER A; ZIMMERMANN DK; ROTH B; WIEG C; GRZESCHIK KH; KOCH MC; SEYBERTH HW; VARGAS R; FORESTIER L; JEAN G; DESCHAUX M; RIZZONI GF; NIAUDET P; ANTIGNAC C; FELDMANN D; LORRIDON F; COUGOUREUX E; LAROZE F; ALESSANDRI JL; DAVID L; SAUNIER P; DESCHENES G; HILDEBRANDT F; VOLLMER M; PROESMANS W; BRANDIS M; VANDENHEUVEL LPJ; LEMMINK HH; NILLESEN W; MONNENS LAH; KNOERS NVAM; GUAYWOODFORD LM; WRIGHT CJ; MADRIGAL G; HEBERT SC
      MUTATIONS IN THE GENE ENCODING THE INWARDLY-RECTIFYING RENAL POTASSIUM CHANNEL, ROMK, CAUSE THE ANTENATAL VARIANT OF BARTTER-SYNDROME - EVIDENCE FOR GENETIC-HETEROGENEITY

      Human molecular genetics
    44. KOMHOFF M; GRONE HJ; KLEIN T; SEYBERTH HW; NUSING RM
      LOCALIZATION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 IN ADULT AND FETAL HUMAN KIDNEY - IMPLICATION FOR RENAL-FUNCTION

      American journal of physiology. Renal, fluid and electrolyte physiology
    45. ASSMANN B; HOFFMANN GF; WAGNER L; BRAUTIGAM C; SEYBERTH HW; DURAN M; VANKUILENBURG ABP; WEVERS R; VANGENNIP AH
      DIHYDROPYRIDMIDINASE DEFICIENCY AND CONGENITAL MICROVILLOUS ATROPHY -COINCIDENCE OR GENETIC RELATION

      Journal of inherited metabolic disease
    46. FARKER K; SCHWEER H; VOLLANDT R; NASSR N; NAGEL U; SEYBERTH HW; HOFFMANN A; OETTEL M
      MEASUREMENTS OF URINARY PROSTAGLANDINS IN YOUNG OVULATORY WOMEN DURING THE MENSTRUAL-CYCLE AND IN POSTMENOPAUSAL WOMEN

      Prostaglandins
    47. LEMMINK HH; KNOERS NAVM; BINDELS RJ; NILLESEN WN; KANSEN M; VANDERKEMP A; MONNENS LAH; VANDENHEUVEL LPWJ; AMIGNAC C; FELDMANN D; HILDEBRANDT F; SEYBERTH HW; GUAYWOODFORD L
      MUTATIONS IN THE INWARDLY-RECTIFYING RENAL POTASSIUM CHANNEL (ROMK) CAUSE THE ANTENATAL VARIANT OF BARTTER-SYNDROME

      Kidney international
    48. BECK KH; KRAUS M; MAGSAAM J; KRETSCHMER V; LEONHARD A; SEYBERTH HW
      PROTHROMBIN MARBURG - A DYSFUNCTIONAL COAGULATION PROTEIN

      Thrombosis research
    49. STIER C; HESS M; WATZER B; SCHWEER H; SEYBERTH HW; LEONHARDT A
      PROSTANOID FORMATION DURING FEEDING OF A PRETERM FORMULA WITH LONG-CHAIN POLYUNSATURATED FATTY-ACIDS IN HEALTHY PRETERM INFANTS DURING THE FIRST WEEKS OF LIFE

      Pediatric research
    50. NUSING RM; SCHAUB TP; KLEIN T; SCHWEER H; SEYBERTH HW
      PROSTANOID BIOSYNTHESIS BY BLOOD MONOCYTES OF CHILDREN WITH HYPERPROSTAGLANDIN-E SYNDROME

      Pediatric research
    51. CAWELLO W; SCHWEER H; DIETRICH B; SEYBERTH HW; ALBRECHT D; FOX A; HOHMUTH H
      PHARMACOKINETICS OF PROSTAGLANDIN-E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN-E1 INPATIENTS WITH ERECTILE DYSFUNCTION

      The Journal of urology
    52. KLEIN T; REUTTER F; SCHWEER H; SEYBERTH HW; NUSING RM
      GENERATION OF THE ISOPROSTANE 8-EPI-PROSTAGLANDIN F2-ALPHA IN-VITRO AND IN-VIVO VIA THE CYCLOOXYGENASES

      The Journal of pharmacology and experimental therapeutics
    53. LEONHARDT A; KRAUS M; GIELER U; SCHWEER H; HAPPLE R; SEYBERTH HW
      IN-VIVO FORMATION OF PROSTAGLANDIN E(1) AND PROSTAGLANDIN E(2) IN ATOPIC-DERMATITIS

      British journal of dermatology
    54. DERST C; KONRAD M; KOCKERLING A; KAROLYI L; DESCHENES G; DAUT J; KARSCHIN A; SEYBERTH HW
      MUTATIONS IN THE ROMK GENE IN ANTENATAL BARTTER-SYNDROME ARE ASSOCIATED WITH IMPAIRED K+ CHANNEL FUNCTION

      Biochemical and biophysical research communications
    55. SCHWEER H; WATZER B; SEYBERTH HW; STEINMETZ A; SCHAEFER JR
      DETERMINATION OF ISOTOPIC-RATIOS OF L-LEUCINE AND L-PHENYLALANINE ANDTHEIR STABLE-ISOTOPE LABELED ANALOGS IN BIOLOGICAL SAMPLES BY GAS CHROMATOGRAPHY TRIPLE-STAGE QUADRUPOLE MASS-SPECTROMETRY/

      Journal of mass spectrometry.
    56. VARGAS R; ANTIGNAC C; JEAN G; FORESTIER L; NIAUDET P; FELDMANN D; DESCHENES G; KAROLYI L; SEYBERTH HW; MADRIGAL G; HILDEBRANDT F; KNOERS NVAM; GUAYWOODFORD LM; HEBERT SC
      PHENOTYPIC VARIABILITY AND GENETIC-HETEROGENEITY IN BARTTER-SYNDROME

      Journal of the American Society of Nephrology
    57. STRANDVIK B; SVENSSON E; SEYBERTH HW
      PROSTANOID BIOSYNTHESIS IN PATIENTS WITH CYSTIC-FIBROSIS

      Prostaglandins, leukotrienes and essential fatty acids
    58. KAROLYI L; ZIEGLER A; POLLAK M; FISCHBACH M; GRZESCHIK KH; KOCH MC; SEYBERTH HW
      GITELMANS-SYNDROME IS GENETICALLY DISTINCT FROM OTHER FORMS OF BARTTERS-SYNDROME

      Pediatric nephrology
    59. FELLMAN V; PIHKO H; MAJANDER A; SEYBERTH HW
      SEVERE HYPERPROSTAGLANDIN-E SYNDROME WITH HYPERTHYROIDISM - STUDIES OF PATHOGENETIC MECHANISMS

      Journal of inherited metabolic disease
    60. KOCKERLING A; REINALTER SC; SEYBERTH HW
      RESISTANCE TO FUROSEMIDE IN HYPERPROSTAGLANDIN-E SYNDROME - EVIDENCE FOR A PROSTAGLANDIN-INDEPENDENT DEFECT IN THE LOOP OF HENLE

      Pediatric research
    61. KOMHOFF M; KLEIN T; SOERGEL M; SEYBERTH HW; NUSING RM
      CONSTITUTIVE EXPRESSION OF PROSTAGLANDIN SYNTHASE (CYCLOOXYGENASE)-1 AND (CYCLOOXYGENASE)-2 IN HUMAN KIDNEY

      Pediatric research
    62. KOCKERLING A; REINALTER SC; SEYBERTH HW
      IMPAIRED RESPONSE TO FUROSEMIDE IN HYPERPROSTAGLANDIN-E SYNDROME - EVIDENCE FOR A TUBULAR DEFECT IN THE LOOP OF HENLE

      The Journal of pediatrics
    63. MEYBURG J; MAYATEPEK E; HOFFMANN GF; LINDERKAMP O; SEYBERTH HW
      SEVERE HYPERCHLORIDURIA-HYPERKALIURIA - A NEW CONGENITAL RENAL TUBULAR ABNORMALITY

      The Journal of pediatrics
    64. LEONHARDT A; MAGSAAM J; GOLDNER M; KUHL PG; SEYBERTH HW
      BIOSYNTHESIS OF PROSTACYCLIN AND THROMBOXANE A(2) DURING CHRONIC HYPOXEMIA IN CHILDREN WITH CYANOTIC CONGENITAL HEART-DISEASE

      European journal of clinical investigation
    65. SEIDEL C; REINALTER S; SEYBERTH HW; SCHARER K
      PRE-PUBERTAL GROWTH IN THE HYPERPROSTAGLANDIN-E SYNDROME

      Pediatric nephrology
    66. CAWELLO W; LEONHARDT A; SCHWEER H; SEYBERTH HW; BONN R; LOMELI AL
      DOSE PROPORTIONAL PHARMACOKINETICS OF ALPROSTADIL (PROSTAGLANDIN E(1)) IN HEALTHY-VOLUNTEERS FOLLOWING INTRAVENOUS-INFUSION

      British journal of clinical pharmacology
    67. WEGMANN M; SEYBERTH HW; KOCKERLING A
      INHIBITORY EFFECT OF 12(R)-HETE ON ION-TRANSPORT IN RAT COLON

      Kidney international
    68. OKSCHE A; DICKSON J; SCHULEIN R; SEYBERTH HW; MULLER M; RASCHER W; BIRNBAUMER M; ROSENTHAL W
      2 NOVEL MUTATIONS IN THE VASOPRESSIN V2-RECEPTOR GENE IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS (VOL 205, PG 552, 1994)

      Biochemical and biophysical research communications
    69. SCHWEER H; WATZER B; SEYBERTH HW
      DETERMINATION OF 7 PROSTANOIDS IN 1 ML OF URINE BY GAS-CHROMATOGRAPHYNEGATIVE-ION CHEMICAL-IONIZATION TRIPLE STAGE QUADRUPOLE MASS-SPECTROMETRY

      Journal of chromatography B. Biomedical applications
    70. SCHWEER H; MEESE CO; WATZER B; SEYBERTH HW
      DETERMINATION OF PROSTAGLANDIN E(1) AND ITS MAIN PLASMA METABOLITES 15-KETO-PROSTAGLANDIN E(0) AND PROSTAGLANDIN E(0) BY GAS-CHROMATOGRAPHYNEGATIVE-ION CHEMICAL-IONIZATION TRIPLE-STAGE QUADRUPOLE MASS-SPECTROMETRY

      Biological mass spectrometry
    71. SCHWEER H; CAWELLO W; SEYBERTH HW
      GAS-CHROMATOGRAPHY NEGATIVE-ION CHEMICAL-IONIZATION TRIPLE QUADRUPOLEMASS-SPECTROMETRIC DETERMINATION AND PHARMACOKINETICS OF ,15-DIOXO-2,3,4,5,20-PENTANOR-19-CARBOXYPROSTANOIC ACID IN PLASMA

      Prostaglandins, leukotrienes and essential fatty acids
    72. SEYBERTH HW
      HOW CAN YOU DIFFERENTIATE NEONATAL BARTTERS-SYNDROME FROM HYPERPROSTAGLANDIN(-URIA)-E(2)-SYNDROME

      Pediatric nephrology
    73. CAWELLO W; SCHWEER H; MULLER R; BONN R; SEYBERTH HW
      METABOLISM AND PHARMACOKINETICS OF PROSTAGLANDIN E(1) ADMINISTERED BGINTRAVENOUS-INFUSION IN HUMAN-SUBJECTS

      European Journal of Clinical Pharmacology
    74. SEYBERTH HW
      PHARMACOLOGICAL PROPERTIES OF UMCKALOABO PREPARED FROM PELARGONIUM-RENIFORMES SIDOIDES

      Monatsschrift fur Kinderheilkunde
    75. SEYBERTH HW; LEONHARDT A; SOERGEL M
      THE HYPERPROSTAGLANDIN-E2-SYNDROME

      Monatsschrift fur Kinderheilkunde
    76. OKSCHE A; DICKSON J; SCHULEIN R; SEYBERTH HW; MULLER M; RASCHER W; BIRNBAUMER M; ROSENTHAL W
      2 NOVEL MUTATIONS IN THE VASOPRESSIN V2 RECEPTOR GENE IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS

      Biochemical and biophysical research communications
    77. TONSHOFF B; BUSCH C; SCHWEER H; SCHARER K; SEYBERTH HW
      IN-VIVO PROSTANOID FORMATION DURING ACUTE RENAL-ALLOGRAFT REJECTION

      Nephrology, dialysis, transplantation
    78. SCHROTER J; TIMMERMANS G; SEYBERTH HW; GREVEN J; BACHMANN S
      MARKED REDUCTION OF TAMM-HORSFALL PROTEIN-SYNTHESIS IN HYPERPROSTAGLANDIN E-SYNDROME

      Kidney international


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 15:18:22